Building a COVID-19 Pop-Up Testing Lab
Bill Gates again discusses coronavirus tests “complete waste”
California Public Health Director Suddenly Quits After Massive Virus Data Error Discovered
Electric Cars: The Lifeline of the Auto Industry
Food insecurity results in long-term health problems
Coronavirus stimulus check news turns to executive orders
Chinese Yuan Advances As PBoC Pledges Targeted Policy
First patients in NIH ACTIV-3 clinical trial enroll in Dallas
COVID-19 could have a lasting, positive impact on workplace culture
Rabo: Once Again The Global Architecture Is At Risk Of Collapse... Which Is Why Markets Will Keep Rising
Pluristem Up 6% In Pre-Market On German Clearance For Covid-19 Study
'Morality pills' may be the US's best shot at ending the coronavirus pandemic, according to one ethicist
As coronavirus curtails travel, backyard pilgrimages become the way to a spiritual journey
How to use ventilation and air filtration to prevent the spread of coronavirus indoors
Blain: "The Brutal Reality Of Slowdown Is Becoming Clearer"
Futures Shrug Off Latest China Sanctions, Approach All Time Highs
WHO Praises Paris Mandatory Mask Order, Warns "Majority Of World Still Susceptible" To COVID-19: Live Updates
AstraZeneca Strikes First China Manufacturing Deal For Covid-19 Candidate
Contact tracing: why some people are giving false contact details to bars and restaurants
Will talks about coronavirus stimulus checks pick up again?
With 160 Vaccine Candidates In Development, Goldman Expects An Economic Boom Once At Least One Is Approved By The End Of 2020
Coronavirus: are cases in the UK rising?
A scientist's plea on coronavirus: now is not the time to relax
PTC Therapeutics Scores Early FDA Nod For Evrysdi; Analyst Stays Sidelined
Dollar on up as GBP/USD dips and hits $1.3091 level
To reduce unemployment, companies should cut hours instead of laying off staff
Sophia Genetics launches AI tool to find COVID-19 ‘unknowns’
Weekly Market Outlook: RBNZ, UK GDP and US Stimulus in focus!
Is The OPEC+ Alliance Coming To An End?
Eli Lilly, Innovent Deliver Encouraging Lung Cancer Data For Sintilimab